DE2549568C3 - 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel - Google Patents

2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Info

Publication number
DE2549568C3
DE2549568C3 DE2549568A DE2549568A DE2549568C3 DE 2549568 C3 DE2549568 C3 DE 2549568C3 DE 2549568 A DE2549568 A DE 2549568A DE 2549568 A DE2549568 A DE 2549568A DE 2549568 C3 DE2549568 C3 DE 2549568C3
Authority
DE
Germany
Prior art keywords
formula
acetoacetate
isobutyl
ester
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2549568A
Other languages
German (de)
English (en)
Other versions
DE2549568A1 (de
DE2549568B2 (de
Inventor
Friedrich Dipl.-Chem. Dr. Bossert
Stanislav Dr. Kazda
Wulf Dr. 5090 Leverkusen Vater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to DE2549568A priority Critical patent/DE2549568C3/de
Priority to NO763608A priority patent/NO145574C/no
Priority to JP51129540A priority patent/JPS5259161A/ja
Priority to BG034575A priority patent/BG24668A3/xx
Priority to BG035341A priority patent/BG25078A3/xx
Priority to BG035342A priority patent/BG25079A3/xx
Priority to BG035343A priority patent/BG24803A3/xx
Priority to BG035344A priority patent/BG24804A3/xx
Priority to BG035345A priority patent/BG24805A3/xx
Priority to CH1381976A priority patent/CH623038A5/de
Priority to RO7688294A priority patent/RO70295A/ro
Priority to NZ182502A priority patent/NZ182502A/xx
Priority to GB45501/76A priority patent/GB1516793A/en
Priority to CS767068A priority patent/CS200499B2/cs
Priority to IL50817A priority patent/IL50817A/xx
Priority to FI763160A priority patent/FI60704C/fi
Priority to AT814276A priority patent/AT352129B/de
Priority to NLAANVRAGE7612198,A priority patent/NL175915C/xx
Priority to PL1976193438A priority patent/PL106084B1/pl
Priority to PL1976201800A priority patent/PL105940B1/pl
Priority to LU76133A priority patent/LU76133A1/xx
Priority to BE172063A priority patent/BE847968A/xx
Priority to PT65797A priority patent/PT65797B/pt
Priority to ES452986A priority patent/ES452986A1/es
Priority to GR52093A priority patent/GR61241B/el
Priority to LU88275C priority patent/LU88275I2/xx
Priority to SE7612308A priority patent/SE423542B/xx
Priority to DK498476A priority patent/DK146762C/da
Priority to ZA766622A priority patent/ZA766622B/xx
Priority to CA264,921A priority patent/CA1085406A/en
Priority to IE2458/76A priority patent/IE43984B1/en
Priority to AU19358/76A priority patent/AU498964B2/en
Priority to FR7633488A priority patent/FR2330395A1/fr
Publication of DE2549568A1 publication Critical patent/DE2549568A1/de
Priority to CS776535A priority patent/CS200500B2/cs
Priority to ES463166A priority patent/ES463166A1/es
Priority to US05/903,573 priority patent/US4154839A/en
Priority to CH567880A priority patent/CH622779A5/de
Publication of DE2549568B2 publication Critical patent/DE2549568B2/de
Priority to HK126/81A priority patent/HK12681A/xx
Application granted granted Critical
Publication of DE2549568C3 publication Critical patent/DE2549568C3/de
Priority to NL930035C priority patent/NL930035I2/nl
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE2549568A 1975-11-05 1975-11-05 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel Expired DE2549568C3 (de)

Priority Applications (39)

Application Number Priority Date Filing Date Title
DE2549568A DE2549568C3 (de) 1975-11-05 1975-11-05 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
NO763608A NO145574C (no) 1975-11-05 1976-10-22 Analogifremgangsmaate til fremstilling av 2,6-dimetyl-3-metoksykarbonyl-4-(2`-nitrofenyl)-1,4-dihydropyridin-5-karboksylsyreisobutylester
JP51129540A JPS5259161A (en) 1975-11-05 1976-10-29 1*44dihydroo2*66dimethyll44 phenyll3*55pyridineedicarbonic acid isobuthylmethyl preparation method and medicine thereof
BG035341A BG25078A3 (bg) 1975-11-05 1976-11-01 Метод за получаване на изобутилов естер на 2,6-диметил-3-метоксикарбонил -4-(нитрофенил)-1,4-дихидропиридин-5-карбоновата киселина
BG035342A BG25079A3 (bg) 1975-11-05 1976-11-01 Метод за получаване на изобутилов естер на 2,6-диметил-3-метоксикарбонил -4-(2'-нитрофенил)-1,4 дихидропиридин-5-карбоновата киселина
BG035343A BG24803A3 (bg) 1975-11-05 1976-11-01 Метод за получаване на изобутилов естер на 2,6-диметил-3-метоксикарбонил 4-(2'-нитрофенил)-1,4-дихидропиридин -5-карбоновата киселина
BG035344A BG24804A3 (bg) 1975-11-05 1976-11-01 Метод за получаване на изобутилов естер на 2,6-диметил-3-метоксикарбонил -4(2'-нитрофенил)-1,4-дихидропиридин-5-карбоновата киселина
BG035345A BG24805A3 (bg) 1975-11-05 1976-11-01 Метод за получаване на изобутилов естер на 2,6-диметил-3-метоксикарбонил -4(2'-нитрофенил)-1,4-дихидропиридин-5-карбоновата киселина
BG034575A BG24668A3 (bg) 1975-11-05 1976-11-01 Метод за получаване на изобутилов естер на 2-6-диметил-3- метоксикарбонил-4-(2'-нитрофенил)-1,4-дихидропиридин-5- карбоновата киселина
RO7688294A RO70295A (ro) 1975-11-05 1976-11-02 Procedeu de preparare a esterului izobutilic al acidului 2,6-dimetil-3-metoxicarbonil-4-(2'-nitrofenil)-1,4-dihidropiridin-5-carboxilic
NZ182502A NZ182502A (en) 1975-11-05 1976-11-02 1,4-dihydro-2,6-dimethyl-3-methoxycarbonyl-5-isobut-oxycarbonyl-4-(21-nitrophenyl)-pyridine and pharmaceutical compositions
CH1381976A CH623038A5 (en) 1975-11-05 1976-11-02 Process for the preparation of novel isobutyl 2,6-dimethyl-3-methoxycarbonyl-4-(2'-nitrophenyl)-1,4-dihydropyridine- 5-carboxylate
GB45501/76A GB1516793A (en) 1975-11-05 1976-11-02 1,4-dihydropyridine-3,5-dicarboxylic acid diester derivative several processes for its preparation and its use as a coronary therapeutic agent
CS767068A CS200499B2 (en) 1975-11-05 1976-11-02 Process for preparing isobutylestere of 2,6-dimethyl-3-methoxycarbonyl-4-/2-nitrophenyl/1,4-dihydropyridin-5-carboxylic acid
IL50817A IL50817A (en) 1975-11-05 1976-11-02 Isobutyl methyl-1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine dicarboxylate,its preparation and pharmaceutical compositions containing it
AT814276A AT352129B (de) 1975-11-05 1976-11-03 Verfahren zur herstellung des neuen 2,6- dimethyl-3-methoxycarbonyl-4-(2'-nitrophenyl)- 1,4-dihydropyridin-5-carbonsaeureisobutylesters
NLAANVRAGE7612198,A NL175915C (nl) 1975-11-05 1976-11-03 Werkwijze voor het bereiden van coronair werkzame preparaten, alsmede werkwijze voor het bereiden van een in dergelijke preparaten toe te passen 2,6-dimethyl-3-methoxycarbonyl-4-(2'-nitrofenyl) -1,4-dihydropyridine-5-carbonzure-ester.
PL1976193438A PL106084B1 (pl) 1975-11-05 1976-11-03 Sposob wytwarzania nowego estru izobutylowego kwasu 2,6-dwumetylo-3-metoksykarbonylo-4-/2'-nitrofenylo/1,4-dwuwodoropirydyno-5-karboksylowego
PL1976201800A PL105940B1 (pl) 1975-11-05 1976-11-03 Sposob wytwarzania nowego estru izobutylowego kwasu 2,6-dwumetylo-3-metoksykarbonylo-4-/2'-nitrofenylo/-1,4-dwuwodoropirydyno-5-karboksylowego
FI763160A FI60704C (fi) 1975-11-05 1976-11-03 Foerfarande foer framstaellning av terapeutiskt anvaendbar 2,6-dimetyl-3-metoxikarbonyl-4-(2'-nitrofenyl)-1,4-dihydropyridin-5-karboxylsyraisobutylester
LU76133A LU76133A1 (enExample) 1975-11-05 1976-11-04
PT65797A PT65797B (de) 1975-11-05 1976-11-04 Peutikum seiner herstellung sowie seine verwendung als coronartheradropyridin-5-carbonsanreisobutylester mehrere verfahren zu2,6-dimethyl-3-methoxycarbonyl-4-(2'-nitrophenyl)-1,4-dihy
ES452986A ES452986A1 (es) 1975-11-05 1976-11-04 Procedimiento para preparar ester isobutilico de acido 2,6- dimetil-3-metoxicarbonil-4-(2'-nitrofenil)-1, 4-dihidropiri-din-5-carboxilico).
GR52093A GR61241B (en) 1975-11-05 1976-11-04 2,6-dimethyl-3-methoxycarbonyl-4-(2-nitrophenyl)-1,4-dihydropyridin-5-isobutylester of carbonic acid preparation process thereof and use thereof as coronartherapeutical
LU88275C LU88275I2 (enExample) 1975-11-05 1976-11-04
SE7612308A SE423542B (sv) 1975-11-05 1976-11-04 Sett att framstella 2,6-dimetyl-3metoxikarbonyl-4-(2'-nitrofenyl)-1,4-dihydropyridin-5-karbonsyraisobutylester
DK498476A DK146762C (da) 1975-11-05 1976-11-04 Analogifremgangsmaade til fremstilling af 2,6-dimethyl-3-methoxycarbonyl-4-(2'-nitrophenyl)-1,4-dihydropyridin-5-carboxylsyreisobutylester
ZA766622A ZA766622B (en) 1975-11-05 1976-11-04 A 1,4-dihydropyridine-3,5-dicarboxylic acid di-ester derivative several processes for its preparation and its use as a coronary therapeutic agent
CA264,921A CA1085406A (en) 1975-11-05 1976-11-04 Isobutyl methyl-1,4-dihydro-2,6-dimethyl-4-(2- nitrophenyl)-3,5-pyridindicarboxylate
IE2458/76A IE43984B1 (en) 1975-11-05 1976-11-04 A 1,4-dihydropyridine-3 5-dicarboxylic acid di-ester derivative, several processes for its preparation,and its use as a coronary therapeutic agent
BE172063A BE847968A (fr) 1975-11-05 1976-11-04 Ester isobutylique de l'acide 2,6-dimethyl-3-methoxyczrbonyl-4-(2'-nitrophenyl)-1,4-dihydropyridine-5-carboxylique, son procede de preparation et medicament a usage coronarien le contenant
AU19358/76A AU498964B2 (en) 1975-11-05 1976-11-05 Isobutyl methyl 1, 4-dihydro-2, 6-dimethyl-4-(2 nitrophenyl)-3, 5-pyridine-dicarboxylate
FR7633488A FR2330395A1 (fr) 1975-11-05 1976-11-05 Ester isobutylique de l'acide 2,6-dimethyl-3-methoxycarbonyl-4-(2'nitrophenyl)-1,4-dihydropyridine-5-carboxylique, son procede de preparation et medicament a usage coronarien le contenant
CS776535A CS200500B2 (cs) 1975-11-05 1977-10-07 Způsob výroby isobutylesteru 2,6-dimethyl-3-methoxykarbonyl-4- -(2'-nitrofenyl)-1,4-dihydropyridin-5-karboxylové kyseliny
ES463166A ES463166A1 (es) 1975-11-05 1977-10-13 Procedimiento para preparar ester isobutilico del acido 2,6-dimetil-3-metoxicarbonil-4-(2'-nitrofenil)-1,4-dihidropiri- din-5-carboxilico.
US05/903,573 US4154839A (en) 1975-11-05 1978-05-08 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
CH567880A CH622779A5 (en) 1975-11-05 1980-07-23 Process for the preparation of novel isobutyl 2,6-dimethyl-3-methoxycarbonyl-4-(2'-nitrophenyl)-1,4-dihydropyridine- 5-carboxylate
HK126/81A HK12681A (en) 1975-11-05 1981-04-02 A 1,4-dihydropyridine-3.5-dicarboxylic acid di-ester derivative,several processes for its preparation,and its use as a coronary therapeutic agent
NL930035C NL930035I2 (nl) 1975-11-05 1993-05-24 Werkwijze voor het bereiden van coronair werkzame preparaten, alsmede werkwijze voor het bereiden van een in dergelijke preparaten toe te passen 2,6-dimethyl-3-methoxycarbonyl-4-(2'-nitrofenyl)-1,4-dihydropyridine-5-carbozure-ester.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2549568A DE2549568C3 (de) 1975-11-05 1975-11-05 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
DE2549568A1 DE2549568A1 (de) 1977-05-18
DE2549568B2 DE2549568B2 (de) 1980-08-21
DE2549568C3 true DE2549568C3 (de) 1981-10-29

Family

ID=5960951

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2549568A Expired DE2549568C3 (de) 1975-11-05 1975-11-05 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel

Country Status (27)

Country Link
JP (1) JPS5259161A (enExample)
AT (1) AT352129B (enExample)
AU (1) AU498964B2 (enExample)
BE (1) BE847968A (enExample)
BG (6) BG25078A3 (enExample)
CA (1) CA1085406A (enExample)
CH (2) CH623038A5 (enExample)
CS (1) CS200499B2 (enExample)
DE (1) DE2549568C3 (enExample)
DK (1) DK146762C (enExample)
ES (2) ES452986A1 (enExample)
FI (1) FI60704C (enExample)
FR (1) FR2330395A1 (enExample)
GB (1) GB1516793A (enExample)
GR (1) GR61241B (enExample)
HK (1) HK12681A (enExample)
IE (1) IE43984B1 (enExample)
IL (1) IL50817A (enExample)
LU (2) LU88275I2 (enExample)
NL (2) NL175915C (enExample)
NO (1) NO145574C (enExample)
NZ (1) NZ182502A (enExample)
PL (2) PL106084B1 (enExample)
PT (1) PT65797B (enExample)
RO (1) RO70295A (enExample)
SE (1) SE423542B (enExample)
ZA (1) ZA766622B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
DE3212736A1 (de) * 1982-04-06 1983-10-13 Bayer Ag, 5090 Leverkusen Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
JPS5982192U (ja) * 1982-11-27 1984-06-02 エムケ−精工株式会社 扉
DE3312216A1 (de) * 1983-04-05 1984-10-11 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von symmetrischen 1,4-dihydropyridincarbonsaeureestern
DE3312283A1 (de) * 1983-04-05 1984-10-18 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von unsymmetrischen 1,4-dihydropyridincarbonsaeureestern
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
ES452986A1 (es) 1977-12-16
AU498964B2 (en) 1979-03-29
DK146762B (da) 1983-12-27
NL175915C (nl) 1985-01-16
NO145574B (no) 1982-01-11
IE43984L (en) 1977-05-05
DK146762C (da) 1984-06-12
ES463166A1 (es) 1978-07-16
SE423542B (sv) 1982-05-10
BG25078A3 (bg) 1978-07-12
ATA814276A (de) 1979-02-15
PT65797B (de) 1978-05-12
BE847968A (fr) 1977-05-04
CA1085406A (en) 1980-09-09
LU88275I2 (enExample) 1994-02-03
JPS5647185B2 (enExample) 1981-11-07
FR2330395B1 (enExample) 1978-12-22
AU1935876A (en) 1978-05-11
DE2549568A1 (de) 1977-05-18
RO70295A (ro) 1981-08-17
FR2330395A1 (fr) 1977-06-03
GB1516793A (en) 1978-07-05
NL7612198A (nl) 1977-05-09
BG24804A3 (bg) 1978-05-12
IL50817A0 (en) 1977-01-31
AT352129B (de) 1979-09-10
NL930035I1 (nl) 1993-08-02
NZ182502A (en) 1978-07-28
FI60704C (fi) 1982-03-10
SE7612308L (sv) 1977-05-06
CH623038A5 (en) 1981-05-15
BG24668A3 (bg) 1978-04-12
NO145574C (no) 1982-04-21
IL50817A (en) 1979-07-25
GR61241B (en) 1978-10-12
HK12681A (en) 1981-04-10
BG25079A3 (bg) 1978-07-12
DK498476A (da) 1977-05-06
BG24805A3 (bg) 1978-05-12
BG24803A3 (bg) 1978-05-12
NL930035I2 (nl) 1993-10-01
ZA766622B (en) 1977-10-26
CH622779A5 (en) 1981-04-30
PL105940B1 (pl) 1979-11-30
PL106084B1 (pl) 1979-11-30
IE43984B1 (en) 1981-07-15
FI60704B (fi) 1981-11-30
NO763608L (enExample) 1977-05-06
CS200499B2 (en) 1980-09-15
LU76133A1 (enExample) 1977-06-02
JPS5259161A (en) 1977-05-16
PT65797A (de) 1976-12-01
DE2549568B2 (de) 1980-08-21
FI763160A7 (enExample) 1977-05-06

Similar Documents

Publication Publication Date Title
EP0002208B1 (de) Nitrosubstituierte 1,4-Dihydropyridine, diese enthaltende Arzneimittel sowie deren Herstellung
EP0088274B1 (de) Neue 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihrer Verwendung in Arzneimitteln
EP0012180B1 (de) Neue 1,4-Dihydropyridinverbindungen, Verfahren zu ihrer Herstellung, die genannten Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
EP0026317B1 (de) Optisch aktive 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0103796B1 (de) Neue Dihydropyrimidine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
DE2210672C3 (de) N-substituierte unsymmetrische 1 ^-Dihydropyridin-S^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117571A1 (de) Unsymmetrische 1,4-Dihydropyridincarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel I. Arfm: Farbenfabriken Bayer AG, 5090 Leverkusen
DE2940833C2 (enExample)
DE2841667A1 (de) Fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2210667A1 (de) Kondensiert aromatisch substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0039863B1 (de) 1,4-Dihydropyridine mit unterschiedlichen Substituenten in 2- und 6-Position, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE2549568C3 (de) 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
EP0127826B1 (de) 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
DE2639257A1 (de) Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2658804A1 (de) Kreislaufbeeinflussende mittel
EP0110259A1 (de) 1,4-Dihydropyridinderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
DE2650013C3 (de) 1.4-Dihydro-2.6-dimethyl-4-(3-nitrophenyl)-3.5-pyridindicarbonsäureisopropyl-(2-propoxy-äthyl)-ester, Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
EP0315018A2 (de) Fluormethoxyphenyl-dihydropyridine, Verfahren zur Herstellung und ihre Verwendung in Arzneimitteln
DE2616995A1 (de) 1.4-dihydropyridine mit schwefelhaltigen substituenten mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0158956B1 (de) 4-(Nitrophenyl)-tetrahydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2406198A1 (de) Verfahren zur herstellung von neuen 2-amino-6-dialkylaminodihydropyridinen und ihre verwendung als arzneimittel
DE2616991A1 (de) Heterocyclisch-substituierte schwefelhaltige dihydropyridine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0167068B1 (de) 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3,5-dicarbonsäure-isopropyl-[2-(3-trifluormethylphenoxy)-ethyl]-ester, mehrere Verfahren zu seiner Herstellung sowie seine Verwendung in Arzneimitteln
DE2210650C3 (de) 2-Amino-6-alkoxy-4,5-dihydropyridin-3,5-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
EP0042092A2 (de) 1,4-Dihydropyridin-carbonsäureamide Verfahren zu deren Herstellung, ihre Verwendung in Arzneimitteln sowie deren Herstellung

Legal Events

Date Code Title Description
OD Request for examination
C3 Grant after two publication steps (3rd publication)
V448 Application of spc

Free format text: PRODUCT NAME: NISOLDIPIN; REGISTRATION NO/DATE: 10143.00.00, 10143.01.00; 19900426

Spc suppl protection certif: 193 75 023

Filing date: 19930514

V457 Spc granted

Free format text: PRODUCT NAME: NISOLDIPIN; REGISTRATION NO/DATE: 10143.00.00, 10143.01.00; 19900426

Spc suppl protection certif: 193 75 023

Filing date: 19930514

V464 Spc expired

Free format text: PRODUCT NAME: NISOLDIPIN; REGISTRATION NO/DATE: 10143.00.00, 10143.01.00; 19900426

Spc suppl protection certif: 193 75 023

Filing date: 19930514